Study estimates the total costs of severe traffic injuries in Finland over two years, revealing that direct costs comprise the majority and occur mostly within the first year post-injury.
I-Mab stops work on CD73; Citius to pursue ‘strategic’ options
Plus, news about General Proximity and PBS Biotech: I-Mab pauses CD73 development: The company is not moving forward with a program … Sign up to